Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Post COVID-19 vaccine Guillain-Barré syndrome

J Nepal Health Res Counc. 2022 Mar 13;19(4):852-854. doi: 10.33314/jnhrc.v19i04.3803.

Abstract

Guillain-Barré syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, although rarely vaccination may be associated with it. We present a case of a 44-year-man who presented with progressive weakness of both lower limbs since 6?days, neurological examination findings were consistent with flaccid-type paraplegia and investigation findings including lumbar puncture and nerve conduction studies were consistent with the diagnosis of Guillain-Barré syndrome. He had received the Johnson and Johnson corona virus disease-19 vaccine intramuscularly 15 days before his presentation. Only potential triggering factor in this case was positive finding of Jansen Vaccine. Keywords: Guillain-Barré syndrome; immunoglobulin; jansen vaccine; polyneuropathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Guillain-Barre Syndrome* / chemically induced
  • Guillain-Barre Syndrome* / diagnosis
  • Humans
  • Male
  • Nepal

Substances

  • COVID-19 Vaccines